Correlation Between Zentalis Pharmaceuticals and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Inozyme Pharma, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Inozyme Pharma.
Diversification Opportunities for Zentalis Pharmaceuticals and Inozyme Pharma
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Zentalis and Inozyme is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Inozyme Pharma
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to generate 1.68 times more return on investment than Inozyme Pharma. However, Zentalis Pharmaceuticals is 1.68 times more volatile than Inozyme Pharma. It trades about 0.0 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.41 per unit of risk. If you would invest 375.00 in Zentalis Pharmaceuticals Llc on August 28, 2024 and sell it today you would lose (27.00) from holding Zentalis Pharmaceuticals Llc or give up 7.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Inozyme Pharma
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Inozyme Pharma |
Zentalis Pharmaceuticals and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Inozyme Pharma
The main advantage of trading using opposite Zentalis Pharmaceuticals and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Zentalis Pharmaceuticals vs. Eliem Therapeutics | Zentalis Pharmaceuticals vs. Scpharmaceuticals | Zentalis Pharmaceuticals vs. Milestone Pharmaceuticals | Zentalis Pharmaceuticals vs. Seres Therapeutics |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |